Cancer
Emerging Triple Inhibitor Combination Targets Malignant Peripheral Nerve Sheath Tumors: A Breakthrough in Precision Medicine
A groundbreaking multicenter collaboration spearheaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), and the...
Rice University and MD Anderson Collaborate to Secure Kleberg Medical Grant for Brain Metastasis Research
Rice University chemist Han Xiao and cancer biologist Dihua Yu from The University of Texas MD Anderson Cancer Center have...
Exploring the Potential of Fecal Microbiota Transplantation to Enhance Recovery in Stem Cell Transplant Patients
A groundbreaking study has unveiled new possibilities for utilizing oral fecal microbiota transplantation (FMT) in the prevention of graft-versus-host disease...
Breakthrough Adjuvant Delivery System Set to Boost Cancer Vaccine Efficacy
Researchers at the Terasaki Institute for Biomedical Innovation have made substantial strides in the realm of cancer vaccine development with...
Empowering T Cells: A New Approach to Cancer Immunotherapy
Recent research from the University of Pittsburgh has unveiled a groundbreaking method for growing T cells in laboratory conditions, enhancing...
Damon Runyon Cancer Research Foundation Grants $3.2 Million to Pioneering Early-Career Scientists
The Damon Runyon Cancer Research Foundation has made headlines with its announcement of the 2025 Damon Runyon-Rachleff Innovation Award recipients,...
Enhanced Survival Rates Observed with Anatomic Lung Resection in Early-Stage Lung Cancer Patients
New research unveiled at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has significant implications for the surgical treatment...
Synergistic Impact of Dual-Targeted Therapies with Chemotherapy Achieves Promising Response Rates in BRAF-Mutated Metastatic Colorectal Cancer
In recent advancements in the treatment of metastatic colorectal cancer (mCRC) characterized by BRAF V600E mutations, researchers have announced compelling...
Blood Test from Alliance Trial Reveals Anti-Inflammatory Drug’s Potential to Reduce Colon Cancer Recurrence Risks
The Alliance for Clinical Trials in Oncology has recently unveiled compelling findings from a randomized phase III clinical trial focused...
Blood Test May Inform Use of Celecoxib to Lower Colon Cancer Recurrence Risk
A recent study from Dana-Farber Brigham Cancer Center has unveiled significant findings regarding the treatment of stage 3 colon cancer,...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!